What is it?
What quercetin is
8Quercetin is a flavonol.
Names, aliases and forms
Potential effects and evidence map
Human evidence does not establish quercetin as a cognitive supplement. A large randomized trial found no improvement in memory, attention, reaction time, psychomotor speed, or cognitive flexibility. Formulation can change exposure, but higher exposure is not evidence of nootropic benefit.
In a 12-week randomized trial, 500 and 1,000 mg/day of quercetin did not improve memory, attention, reaction time, psychomotor speed, or cognitive flexibility.
Typical dosages and timing
A 12-week randomized cognition trial used 500 or 1,000 mg/day and found no improvement. This is study context, not a personal dose recommendation or a claim that every formulation is dose-equivalent.
Timing & effect horizon
Safety, side effects and risk profile
The safety review notes medication-bioavailability signals from animal and short-term human work; this does not establish a universal clinical drug-interaction list.
The safety review reports a pre-damaged-kidney finding in an animal model; this does not establish human kidney harm.
Individual tolerability can vary with concentrated supplements and formulation; the cited review does not support a reliable event-rate forecast.
Human pregnancy and breastfeeding safety data for concentrated quercetin supplements are insufficient.
Plain, dihydrate, glycoside, and enhanced formulations can produce different exposure, while exposure differences do not establish cognitive benefit.
The safety review describes reported trial adverse effects as generally mild or rare, but adequate data for longer-term use at high doses are lacking. Product-specific questions and existing medical conditions need individual consideration.
Interactions and cautions
The safety review describes medication-bioavailability signals from animal and short-term human work, not a universal clinical drug-interaction list. Discuss supplements and medicines with a clinician or pharmacist when medicines or clinician-directed care are already in use.
Legal and regulatory status
As of 2026, U.S. dietary-supplement companies are responsible for safety and labeling before marketing; FDA can act against unsafe or unlawful products. This is U.S. regulatory context, not a global approval determination.
How it compares
Human intervention studies show that chemical form, delivery system, and food matrix can change quercetin exposure. Exposure is not a measure of cognitive benefit, so compare the exact formulation and label rather than assuming interchangeable milligrams.
Practical buying and quality notes
- The dated catalog snapshot contains 14 powder and eight capsule rows, but duplicate-like records, zero-quantity or zero-normalized-price rows, and mixed or enhanced formulations make a universal best-price or per-dose ranking unreliable. Confirm the exact form and label before comparing.9
FAQ
What quercetin dose has been studied for cognition?
1The 12-week randomized trial did not establish a personal dose for cognition. This is study context, not a personal dose recommendation.
How long should quercetin be taken?
6There is no evidence-based duration or cycling protocol for cognitive benefit. The safety review found that adequate long-term data for high-dose quercetin were lacking.
References
- Broman-Fulks JJ, Canu WH, Trout KL, Nieman DC. The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebo-controlled trial. Ther Adv Psychopharmacol. 2012.
- Serban MC, Sahebkar A, Zanchetti A, et al. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2016.
- The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020.
- The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta-analyses of randomized controlled trials. Phytother Res. 2023.
- Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies. Food Chem. 2025.
- Andres S, Pevny S, Ziegenhagen R, et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement. Mol Nutr Food Res. 2018.
- U.S. Food and Drug Administration. Dietary Supplements.
- National Center for Biotechnology Information. PubChem Compound Summary for CID 5280343, Quercetin.
- NootropicsIndex Quercetin product catalog snapshot, 1 August 2026.